Chalcone analog-based 5-reductase 1 inhibition in neurosteroidogenesis: Mechanistic insights from integrated SPR binding, enzyme kinetics, 3D-QSAR, and docking.

This study systematically evaluates the inhibitory effects and mechanistic actions of chalcone and 10 chalcone analogs from herbs against human and rat 5α-reductase type 1 (5α-R1), a key enzyme in dihydrotestosterone biosynthesis (for neurosteroid and androgen biosynthesis). Screening of these chemicals identified licochalcone A as the most potent inhibitor (human IC50 = 4.08 μM; rat IC50 = 4.55 μM), displaying 5.15-fold higher binding affinity than the weakest analog (4-hydroxychalcone) via surface plasmon resonance. Michaelis-Menten kinetics revealed mixed inhibition, corroborated by intersecting Lineweaver-Burk plots. SPR competitive assay showed that 4-hydroxychalcone and licochalcone A competed with NADPH in cofactor binding site of human 5α-R1. Cellular assays confirmed licochalcone A's efficacy in suppressing dihydrotestosterone production (≥1 μM in SF-126 cells). Structure-activity relationship (SAR) analysis highlighted lipophilicity (logP), steric bulk (Vol, Sterimol B5), and heteroatom count as critical determinants of potency, validated by a 3D-QSAR pharmacophore model. Molecular docking localized chalcone binding to NADPH/testosterone interfacial sites, with licochalcone A forming hydrogen bonds (Asp169, Arg232) and hydrophobic interactions. ADMET profiling indicated favorable blood-brain barrier penetration but flagged hepatotoxicity for licochalcone A. These findings position licochalcone A as a lead compound for targeting 5α-R1 in neurosteroid/androgen-related disorders.

• Publication year

  2025

• Venue

  Bioorganic chemistry (Print)

• Publication date

  2025-11-16

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.bioorg.2025.109261PMID 41265206
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Phenylthiourea synergistically enhances the hepatotoxicity of bavachalcone by interfering with metabolism in zebrafish: A factor to consider when evaluating toxicity of environmental pollutants using zebrafish models.

  2025cited by this paper
• Neuroprotective effects of bavachalcone in a mouse model of Parkinson’s disease: linking the gut-brain axis and systemic metabolism

  2025cited by this paper
• Detection and pharmacokinetics of licochalcone A in brains of neuroinflammatory mouse model

  2025cited by this paper
• Structure-activity relationships of halogenated disinfectants as potent inhibitors of 5α-reductase type 1: Potential impact on neurosteroid synthesis.

  2025cited by this paper
• Synthesis, biological screening and computational analysis of Thiazole linked Thiazolidinone Schiff bases as anti-Alzheimer's drug candidates.

  2025cited by this paper
• Facile 3-chloro-1H-indazole based 1,3,4-thiadiazole derivatives as novel thymidine phosphorylase and anti-diabetic inhibitors: Experimental, in-vitro and molecular modelling approaches

  2025cited by this paper
• In silico identification of promising PD-L1 inhibitors from selected indian medicinal plants for treatment of triple negative breast cancer

  2025cited by this paper
• Organotins as inhibitors targeting human and rat steroid 5α-reductase 1: structure-activity relationship and docking analysis.

  2025cited by this paper
• New Directions in Neurosteroid Therapeutics in Neuropsychiatry.

  2025cited by this paper
• Molecular Evidence of the Bio-activities of Traditional Home Medicine Ingredients.

  2024cited by this paper
• Endocrine-Disrupting Effects of Salicylate Preservatives on Neurosteroidogenesis: Targeting 5α-Reductase Type 1.

  2024cited by this paper
• Structural determinants of parabens in inhibiting human and rat gonadal 3β-hydroxysteroid dehydrogenase.

  2024cited by this paper
• Paraben preservatives exhibit inhibition on human and rat steroid 5α-reductase 1: A comprehensive 3D-QSAR and computational analysis.

  2024cited by this paper
• Licochalcone A attenuates NMDA-induced neurotoxicity

  2024cited by this paper
• Expanding the therapeutic potential of neuro(active)steroids: a promising strategy for hyperdopaminergic behavioral phenotypes.

  2024cited by this paper
• Carbon-chain length determines the binding affinity and inhibitory strength of per- and polyfluoroalkyl substances on human and rat steroid 5α-reductase 1 activity.

  2024cited by this paper
• Chalcone derivatives from licorice inhibit human and rat gonadal 3β-hydroxysteroid dehydrogenases as therapeutic uses.

  2023cited by this paper
• Natural products in traditional Chinese medicine: molecular mechanisms and therapeutic targets of renal fibrosis and state-of-the-art drug delivery systems.

  2023cited by this paper
• Chalcones from plants cause toxicity by inhibiting human and rat 11β-hydroxysteroid dehydrogenase 2: 3D-quantitative structure-activity relationship (3D-QSAR) and in silico docking analysis.

  2023cited by this paper
• Chalcones as Potential Cyclooxygenase-2 Inhibitors: A Review.

  2023cited by this paper
• Neurosteroid Influence on Affective Tone.

  2023cited by this paper
• Progesterone and its derivatives for the treatment of catamenial epilepsy: A systematic review.

  2023cited by this paper
• Homology Modeling, Molecular Docking, Molecular Dynamic Simulation, and Drug-Likeness of the Modified Alpha-Mangostin against the β-Tubulin Protein of Acanthamoeba Keratitis

  2022cited by this paper
• Derailed peripheral circadian genes in polycystic ovary syndrome patients alters peripheral conversion of androgens synthesis.

  2022cited by this paper
• Neurosteroids (allopregnanolone) and alcohol use disorder: From mechanisms to potential pharmacotherapy.

  2022cited by this paper
• Association of 5α-Reductase Inhibitors With Dementia, Depression, and Suicide

  2022cited by this paper
• Isolation and Characterization of Compounds from Glycyrrhiza uralensis as Therapeutic Agents for the Muscle Disorders

  2021cited by this paper
• AlphaFold Protein Structure Database: massively expanding the structural coverage of protein-sequence space with high-accuracy models

  2021cited by this paper
• OUP accepted manuscript

  2021cited by this paper
• Biotransformation of the Phenolic Constituents from Licorice and Cytotoxicity Evaluation of Their Metabolites

  2021cited by this paper
• Isobavachalcone ameliorates cognitive deficits, and Aβ and tau pathologies in triple-transgenic mice with Alzheimer's disease.

  2021cited by this paper
• Highly accurate protein structure prediction with AlphaFold

  2021cited by this paper
• ADMETlab 2.0: an integrated online platform for accurate and comprehensive predictions of ADMET properties

  2021cited by this paper
• Chalcone and its analogs: Therapeutic and diagnostic applications in Alzheimer's disease.

  2021cited by this paper
• Crystal structure of steroid reductase SRD5A reveals conserved steroid reduction mechanism

  2020cited by this paper
• Chalcone Scaffolds as Anticancer Drugs: A Review on Molecular Insight in Action of Mechanisms and Anticancer Properties.

  2020cited by this paper
• Nrf2 signaling and autophagy are complementary in protecting lipopolysaccharide/d-galactosamine-induced acute liver injury by licochalcone A

  2019cited by this paper
• Adverse Effects and Safety of 5-alpha Reductase Inhibitors (Finasteride, Dutasteride): A Systematic Review.

  2016cited by this paper
• Neurosteroids in hepatic encephalopathy: Novel insights and new therapeutic opportunities.

  2016cited by this paper
• Progesterone and allopregnanolone in the central nervous system: response to injury and implication for neuroprotection.

  2015cited by this paper
• The 5α-reductase inhibitor Dutasteride but not Finasteride protects dopamine neurons in the MPTP mouse model of Parkinson's disease.

  2015cited by this paper
• Female mice with deletion of Type One 5α-reductase have reduced reproductive responding during proestrus and after hormone-priming.

  2014cited by this paper
• Importance of 5α-Reductase Gene Polymorphisms on Circulating and Intraprostatic Androgens in Prostate Cancer

  2013cited by this paper
• The Implication of Neuroactive Steroids in Tourette's Syndrome Pathogenesis: A Role for 5α‐Reductase?

  2013cited by this paper
• Reduced Bone Mass and Muscle Strength in Male 5α-Reductase Type 1 Inactivated Mice

  2011cited by this paper
• Neurosteroids: endogenous role in the human brain and therapeutic potentials.

  2010cited by this paper
• The effect of 5alpha-reductase inhibition with dutasteride and finasteride on bone mineral density, serum lipoproteins, hemoglobin, prostate specific antigen and sexual function in healthy young men.

  2008cited by this paper
• Down-regulation of neurosteroid biosynthesis in corticolimbic circuits mediates social isolation-induced behavior in mice

  2007cited by this paper
• Characterization of brain neurons that express enzymes mediating neurosteroid biosynthesis

  2006cited by this paper
• ZINC - A Free Database of Commercially Available Compounds for Virtual Screening

  2005cited by this paper

• No citing papers are available for this paper.